The current stock price of VMD is 6.87 USD. In the past month the price increased by 6.35%. In the past year, price decreased by -20.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.55 | 100.41B | ||
| CI | THE CIGNA GROUP | 9.63 | 73.08B | ||
| LH | LABCORP HOLDINGS INC | 16.92 | 22.19B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 119.97 | 22.07B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.83 | 20.44B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.56B | ||
| HIMS | HIMS & HERS HEALTH INC | 69.46 | 8.54B | ||
| DVA | DAVITA INC | 12.92 | 8.42B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 35.2 | 6.47B | ||
| RDNT | RADNET INC | 210.55 | 6.17B | ||
| CHE | CHEMED CORP | 19.9 | 6.20B | ||
| OPCH | OPTION CARE HEALTH INC | 20.77 | 4.91B |
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana and currently employs 1,179 full-time employees. The company went IPO on 2017-12-22. The firm focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. The company offers in-home sleep apnea testing services. The firm also provides healthcare staffing and recruitment services.
VIEMED HEALTHCARE INC
625 E. Kaliste Saloom Rd.
Lafayette LOUISIANA 70508 US
CEO: Casey Hoyt
Employees: 1179
Phone: 13375043802
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana and currently employs 1,179 full-time employees. The company went IPO on 2017-12-22. The firm focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. The company offers in-home sleep apnea testing services. The firm also provides healthcare staffing and recruitment services.
The current stock price of VMD is 6.87 USD. The price decreased by -0.58% in the last trading session.
VMD does not pay a dividend.
VMD has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The PE ratio for VIEMED HEALTHCARE INC (VMD) is 20.82. This is based on the reported non-GAAP earnings per share of 0.33 and the current share price of 6.87 USD.
You can find the ownership structure of VIEMED HEALTHCARE INC (VMD) on the Ownership tab.
ChartMill assigns a technical rating of 4 / 10 to VMD. When comparing the yearly performance of all stocks, VMD is a bad performer in the overall market: 75.18% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to VMD. Both the profitability and the financial health of VMD get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months VMD reported a non-GAAP Earnings per Share(EPS) of 0.33. The EPS increased by 22.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.34% | ||
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| Debt/Equity | 0.15 |
7 analysts have analysed VMD and the average price target is 13.26 USD. This implies a price increase of 93.01% is expected in the next year compared to the current price of 6.87.
For the next year, analysts expect an EPS growth of 31.06% and a revenue growth 18.33% for VMD